<SEC-DOCUMENT>0001950047-25-010705.txt : 20251229
<SEC-HEADER>0001950047-25-010705.hdr.sgml : 20251229
<ACCEPTANCE-DATETIME>20251229090543
ACCESSION NUMBER:		0001950047-25-010705
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251229
DATE AS OF CHANGE:		20251229

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		251603857

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		7TH FLOOR, 50 BROADWAY
		CITY:			LONDON
		NON US STATE TERRITORY:  	UNITED KINGDOM
		PROVINCE COUNTRY:   	X0
		ZIP:			SW1H 0DB
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		7TH FLOOR, 50 BROADWAY
		CITY:			LONDON
		NON US STATE TERRITORY:  	UNITED KINGDOM
		PROVINCE COUNTRY:   	X0
		ZIP:			SW1H 0DB

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Torti Frank
		CENTRAL INDEX KEY:			0001647805
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		2855 SAND HILL ROAD
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001647805</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001635088</issuerCik>
            <issuerName>ROIVANT SCIENCES LTD.</issuerName>
            <secFileNumber>001-40782</secFileNumber>
            <issuerAddress>
                <ns2:street1>7th Floor 50 Broadway</ns2:street1>
                <ns2:city>London</ns2:city>
                <ns2:stateOrCountry>X0</ns2:stateOrCountry>
                <ns2:zipCode>SW1H 0DB</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>44 207 400 3347</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>FRANK M TORTI</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>64891</noOfUnitsSold>
            <aggregateMarketValue>1458373.31</aggregateMarketValue>
            <noOfUnitsOutstanding>695491615</noOfUnitsOutstanding>
            <approxSaleDate>12/24/2025</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>12/23/2025</acquiredDate>
            <natureOfAcquisitionTransaction>Restricted stock vesting under a registered plan</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>64891</amountOfSecuritiesAcquired>
            <paymentDate>12/23/2025</paymentDate>
            <natureOfPayment>Stock Swap</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <remarks>Sales that were executed on December 24, 2025 are being reported on this Form 144 filed on December 29, 2025 given December 24, 2025 and December 26, 2025 were treated as federal holidays for EDGAR filing purposes</remarks>
        <noticeSignature>
            <noticeDate>12/29/2025</noticeDate>
            <planAdoptionDates/>
            <signature>/s/ Frank Torti</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
